Upgrade to see committee overlap, performance context, and full expert analysis.
LIN congressional trades
29 matched disclosures
LIN congressional trades snapshot
This page summarizes public STOCK Act disclosures involving LIN. It is useful for seeing which lawmakers reported LIN transactions, how many filings are visible, the buy/sell mix, and whether the newest public filing describes a recent or delayed trade.
Apr 13, 2026
Public House and Senate STOCK Act disclosures normalized by Congressional Trader.
Filing date can trail transaction date. This page is for research and monitoring, not investment advice.
What the LIN congressional trade page shows
Congressional Trader tracks 29 public STOCK Act disclosures for LINacross 12 lawmakers. This page separates purchases from sales, shows filing delays, and links each disclosure back to the individual politician profile when available.
The most recent LIN filing shown here was filed on Apr 13, 2026 by Thomas H. Kean as a purchase. Related lawmakers include Jared Moskowitz, Jefferson Shreve, Kevin Hern, Robert P. Bresnahan, Gilbert Ray Cisneros.
Top lawmakers for LIN
Pro performance summary
Unlock 30/90-day post-trade summaries, committee overlap, and CSV-oriented research views for high-intent ticker research.
Compare Pro plansUpgrade to see committee overlap, performance context, and full expert analysis.
Upgrade to see committee overlap, performance context, and full expert analysis.
Upgrade to see committee overlap, performance context, and full expert analysis.
Upgrade to see committee overlap, performance context, and full expert analysis.
Upgrade to see committee overlap, performance context, and full expert analysis.
Upgrade to see committee overlap, performance context, and full expert analysis.
Upgrade to see committee overlap, performance context, and full expert analysis.
Upgrade to see committee overlap, performance context, and full expert analysis.
Upgrade to see committee overlap, performance context, and full expert analysis.
Upgrade to see committee overlap, performance context, and full expert analysis.
Upgrade to see committee overlap, performance context, and full expert analysis.
Upgrade to see committee overlap, performance context, and full expert analysis.
Upgrade to see committee overlap, performance context, and full expert analysis.
Upgrade to see committee overlap, performance context, and full expert analysis.
Upgrade to see committee overlap, performance context, and full expert analysis.
Upgrade to see committee overlap, performance context, and full expert analysis.
Upgrade to see committee overlap, performance context, and full expert analysis.
Upgrade to see committee overlap, performance context, and full expert analysis.
Upgrade to see committee overlap, performance context, and full expert analysis.
Upgrade to see committee overlap, performance context, and full expert analysis.
Upgrade to see committee overlap, performance context, and full expert analysis.
Upgrade to see committee overlap, performance context, and full expert analysis.
Upgrade to see committee overlap, performance context, and full expert analysis.
Upgrade to see committee overlap, performance context, and full expert analysis.
Upgrade to see committee overlap, performance context, and full expert analysis.
Upgrade to see committee overlap, performance context, and full expert analysis.
Upgrade to see committee overlap, performance context, and full expert analysis.
Upgrade to see committee overlap, performance context, and full expert analysis.
FAQ
Which lawmakers traded LIN?
Recent LIN disclosures include Jared Moskowitz, Jefferson Shreve, Kevin Hern, Robert P. Bresnahan, Gilbert Ray Cisneros.
What is the buy/sell mix for LIN?
The visible sample currently shows 17 purchases and 12 sales or partial sales.
Should I trade based on LIN disclosures?
No. This page summarizes public filings for research and monitoring. It is not investment advice.